218 related articles for article (PubMed ID: 23256951)
21. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).
Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y
Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064
[TBL] [Abstract][Full Text] [Related]
22. Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis.
Heale LD; Houghton KM; Rezaei E; Baxter-Jones ADG; Tupper SM; Muhajarine N; Benseler SM; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Duffy KW; Ellsworth J; Guzman J; Huber AM; Jurencak R; Lang B; Laxer RM; Morishita K; Oen KG; Petty RE; Ramsey SE; Roth J; Schneider R; Scuccimarri R; Spiegel L; Stringer E; Tse SML; Tucker LB; Turvey SE; Yeung RSM; Rosenberg AM;
Pediatr Rheumatol Online J; 2021 Jun; 19(1):97. PubMed ID: 34187498
[TBL] [Abstract][Full Text] [Related]
23. Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China.
Liu DW; Chen JJ; Tang XM; Zhang Y; Zhou J
World J Pediatr; 2020 Feb; 16(1):68-73. PubMed ID: 31612428
[TBL] [Abstract][Full Text] [Related]
24. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
Shyen S; Amine B; Rostom S; E L Badri D; Ezzahri M; Mawani N; Moussa F; Gueddari S; Wabi M; Abouqal R; Chkirate B; Hajjaj-Hassouni N
Clin Rheumatol; 2014; 33(10):1425-31. PubMed ID: 24135889
[TBL] [Abstract][Full Text] [Related]
25. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.
Consolaro A; Bracciolini G; Ruperto N; Pistorio A; Magni-Manzoni S; Malattia C; Pederzoli S; Davì S; Martini A; Ravelli A;
Arthritis Rheum; 2012 Jul; 64(7):2366-74. PubMed ID: 22231288
[TBL] [Abstract][Full Text] [Related]
26. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
[TBL] [Abstract][Full Text] [Related]
27. Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.
Klein A; Minden K; Hospach A; Foeldvari I; Weller-Heinemann F; Trauzeddel R; Huppertz HI; Horneff G
Ann Rheum Dis; 2020 Jul; 79(7):969-974. PubMed ID: 32299797
[TBL] [Abstract][Full Text] [Related]
28. Uric acid could be a marker of cardiometabolic risk and disease severity in children with juvenile idiopathic arthritis.
Gicchino MF; Marzuillo P; Zarrilli S; Melone R; Guarino S; Miraglia Del Giudice E; Olivieri AN; Di Sessa A
Eur J Pediatr; 2023 Jan; 182(1):149-154. PubMed ID: 36229695
[TBL] [Abstract][Full Text] [Related]
29. Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis.
Gueddari S; Amine B; Rostom S; Badri D; Mawani N; Ezzahri M; Moussa F; Shyen S; Abouqal R; Chkirat B; Hajjaj-Hassouni N
Clin Rheumatol; 2014 Sep; 33(9):1289-94. PubMed ID: 24651917
[TBL] [Abstract][Full Text] [Related]
30. Strong relationships between disease activity, foot-related impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis.
Dekker M; Hoeksma AF; Dekker JH; van Rossum MA; Dolman KM; Beckerman H; Roorda LD
Clin Exp Rheumatol; 2010; 28(6):905-11. PubMed ID: 21122275
[TBL] [Abstract][Full Text] [Related]
31. An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.
Zare N; Mansoubi M; Coe S; Najafi AA; Bailey K; Harrison K; Sheehan J; Dawes H; Barker K
BMC Pediatr; 2023 Jan; 23(1):3. PubMed ID: 36593466
[TBL] [Abstract][Full Text] [Related]
32. Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score.
Horneff G; Becker I
Rheumatology (Oxford); 2014 Jul; 53(7):1229-34. PubMed ID: 24599918
[TBL] [Abstract][Full Text] [Related]
33. A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q.
Unal E; Batu ED; Sonmez HE; Arici ZS; Arin G; Karaca NB; Sag E; Demir S; Hakli DA; Ozcadirci A; Oflaz FB; Alpar R; Bilginer Y; Ozen S
Rheumatol Int; 2018 Aug; 38(8):1557-1564. PubMed ID: 29869009
[TBL] [Abstract][Full Text] [Related]
34. Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity.
Gheita TA; Bassyouni IH; Emad Y; el-Din AM; Abdel-Rasheed E; Hussein H
Joint Bone Spine; 2012 May; 79(3):285-90. PubMed ID: 21733733
[TBL] [Abstract][Full Text] [Related]
35. The dual role of body mass index on Juvenile Idiopathic Arthritis course: a pediatric experience.
Gicchino MF; Marzuillo P; Melone R; Zarrilli S; Miraglia Del Giudice E; Olivieri AN; Di Sessa A
Eur J Pediatr; 2024 Feb; 183(2):809-813. PubMed ID: 38015262
[TBL] [Abstract][Full Text] [Related]
36. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
37. Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study.
Gruszewska E; Sienkiewicz M; Abramowicz P; Konstantynowicz J; Gudowska-Sawczuk M; Chrostek L; Cylwik B
Rheumatol Int; 2018 Jul; 38(7):1235-1240. PubMed ID: 29761223
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
[TBL] [Abstract][Full Text] [Related]
39. Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.
Backström M; Tynjälä P; Ylijoki H; Aalto K; Kärki J; Pohjankoski H; Keskitalo P; Sard S; Hietanen M; Lehto H; Kauko T; Vähäsalo P
Rheumatology (Oxford); 2016 Apr; 55(4):615-23. PubMed ID: 26447164
[TBL] [Abstract][Full Text] [Related]
40. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Viswanath V; Myles A; Dayal R; Aggarwal A
J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
